安信龙保险 AIZ 深 沪
等待开盘 10-19 09:30:00 美东时间
283.31
+1.440
+0.51%
华盛通- 最 高285.67
- 今 开281.97
- 成交量 39.93万股
- 最 低 281.8325
- 昨 收 281.87
- 总市值 139.74亿
- 52周最高 303.06
- 市盈率 静 16.58
- 换手率 0.81%
- 52周最低 202.51
- 委 比 0.00%
- 总股本 4932.38万
- 历史最高 303.06
- 量 比 1.07
- 振 幅 1.36%
- 历史最低 -0.55
- 每 手 1
- 风险率 25.69%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股盘后 | 新美亚电子大升7.13%，Pershing Square上升3.75%
新美亚电子大升7.13%；Pershing Square上升3.75%；数字房地产信托公司上升2.36%
10-15 06:10
Here’s How Much You Would Have Made Owning Assurant Stock In The Last 15 Years
Assurant (NYSE:AIZ) has outperformed the market over the past 15 years by 1.13% on an annualized basis producing an average annual return of 14.2%. Currently, Assurant has a market capitalization of $13.16 billion. Buying $100 In AIZ: If an investor had bought $100 of AIZ stock 15 years ago, it woul...
10-09 04:30
美股大行评级 | 花旗看高AMD至800美元！富国上调Meta目标价至1000美元
今日重点评级关注：Jones Trading：维持Opus Genetics"买入"评级，目标价从10美元升至17美元；Citizens：维持Rezolute"跑赢大市"评级，目标价从11美元升至15美元
10-07 17:30
Morgan Stanley Maintains Overweight on Assurant, Lowers Price Target to $300
Morgan Stanley analyst Bob Huang maintains Assurant (NYSE:AIZ) with a Overweight and lowers the price target from $320 to $300.
10-07 01:09
美股大行评级 | 潜在涨幅768.26%！Ascendiant Capital维持RenovoRx(RNXT)"买入"评级，目标价上调至14.5美元
今日重点评级关注：Ascendiant Capital：维持RenovoRx"买入"评级，目标价从14美元升至14.5美元；HC Wainwright & Co.：维持Generate Biomedicines"买入"评级，目标价从25美元升至30美元
08-31 18:14
BMO Capital Maintains Outperform on Assurant, Raises Price Target to $320
BMO Capital analyst Charlie Lederer maintains Assurant (NYSE:AIZ) with a Outperform and raises the price target from $274 to $320.
08-28 20:40
美股大行评级 | 潜在涨幅544.53%！Scynexis获古根海姆升目标价至33美元，维持"买入"评级
今日重点评级关注：古根海姆：维持Scynexis"买入"评级，目标价从24美元升至33美元；韦德布什：维持Kura Oncology"跑赢大市"评级，目标价从36美元升至38美元
08-14 11:51
UBS Maintains Buy on Assurant, Raises Price Target to $331
UBS analyst Brian Meredith maintains Assurant (NYSE:AIZ) with a Buy and raises the price target from $274 to $331.
08-14 05:17
美股大行评级 | 花旗下调美光科技目标价从1400美元降至1150美元；爱彼迎、Datadog、Cloudflare、Etsy、Natera、拉夫劳伦获多家大行上调目标价
今日重点评级关注：康托·菲茨杰拉德：维持InflaRx"超配"评级，目标价从4美元升至6美元；RBC Capital：维持Nuvation Bio"跑赢大市"评级，目标价从19美元升至20美元
08-10 19:24
Atlassian To Rally More Than 63%? Here Are 10 Top Analyst Forecasts For Friday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. HC Wainwright & Co raised the price target for Halozyme Therapeutics, Inc. (NASDAQ:HALO) from $95 to $115. HC ...
08-07 20:45
